Pomalidomide: A New Option for Relapsed Myeloma

ATLANTA (IMNG) - Patients with refractory multiple myeloma, including those with heavily pretreated disease, lived significantly longer with the immunomodulatory drug pomalidomide plus low-dose dexamethasone...
Source: OncologySTAT Latest News - Category: Cancer & Oncology Source Type: news